Myeloid Cells Restrict MCMV and Drive Stress-Induced Extramedullary Hematopoiesis through STAT1.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Gawish, RiemBulat, Tanja
Biaggio, Mario
Lassnig, Caroline
Bago-Horvath, Zsuzsanna
Macho-Maschler, Sabine
Poelzl, Andrea
Simonović, Natalija
Prchal-Murphy, Michaela
Rom, Rita
Amenitsch, Lena
Ferrarese, Luca
Kornhoff, Juliana
Lederer, Therese
Svinka, Jasmin
Eferl, Robert
Bosmann, Markus
Kalinke, Ulrich
Stoiber, Dagmar
Sexl, Veronika
Krmpotić, Astrid
Jonjić, Stipan
Müller, Mathias
Strobl, Birgit
Issue Date
2019-02-26
Metadata
Show full item recordAbstract
Cytomegalovirus (CMV) has a high prevalence worldwide, is often fatal for immunocompromised patients, and causes bone marrow suppression. Deficiency of signal transducer and activator of transcription 1 (STAT1) results in severely impaired antiviral immunity. We have used cell-type restricted deletion of Stat1 to determine the importance of myeloid cell activity for the defense against murine CMV (MCMV). We show that myeloid STAT1 limits MCMV burden and infection-associated pathology in the spleen but does not affect ultimate clearance of infection. Unexpectedly, we found an essential role of myeloid STAT1 in the induction of extramedullary hematopoiesis (EMH). The EMH-promoting function of STAT1 was not restricted to MCMV infection but was also observed during CpG oligodeoxynucleotide-induced sterile inflammation. Collectively, we provide genetic evidence that signaling through STAT1 in myeloid cells is required to restrict MCMV at early time points post-infection and to induce compensatory hematopoiesis in the spleen.Citation
Cell Rep. 2019 Feb 26;26(9):2394-2406.e5. doi: 10.1016/j.celrep.2019.02.017.Affiliation
TWINCORE, Zentrum für experimentelle und klinische Infektionsforschung GmbH, Feodor-Lynen-Str.7,30625 Hannover, Germany.Publisher
ElsevierJournal
Cell ReportsPubMed ID
30811989Type
ArticleLanguage
enISSN
2211-1247ae974a485f413a2113503eed53cd6c53
10.1016/j.celrep.2019.02.017
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
- Authors: Cocita C, Guiton R, Bessou G, Chasson L, Boyron M, Crozat K, Dalod M
- Issue date: 2015 May
- Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection.
- Authors: Jordan S, Ruzsics Z, Mitrović M, Baranek T, Arapović J, Krmpotić A, Vivier E, Dalod M, Jonjić S, Dölken L, Koszinowski UH
- Issue date: 2013 May 15
- Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.
- Authors: Tay CH, Welsh RM
- Issue date: 1997 Jan
- "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
- Authors: Trilling M, Le VT, Rashidi-Alavijeh J, Katschinski B, Scheller J, Rose-John S, Androsiac GE, Jonjic S, Poli V, Pfeffer K, Hengel H
- Issue date: 2014 Jan 1
- Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide.
- Authors: Madera S, Rapp M, Firth MA, Beilke JN, Lanier LL, Sun JC
- Issue date: 2016 Feb 8